ANEXATE

This brand name is authorized in Austria, Croatia, Estonia, Hong Kong SAR China, Ireland, Japan, Lithuania, Netherlands, New Zealand, Romania, Singapore, Spain.

Active ingredients

The drug ANEXATE contains one active pharmaceutical ingredient (API):

1
UNII 40P7XK9392 - FLUMAZENIL
 

Flumazenil, an imidazobenzodiazepine, is a benzodiazepine antagonist which, by competitive interaction, blocks the effects of substances acting via the benzodiazepine-receptor. Neutralisation of paradoxal reactions of benzodiazepines has been reported.

 
Read more about Flumazenil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V03AB25 Flumazenil V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB25

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1000584
ES Centro de información online de medicamentos de la AEMPS 57806, 57807
HK Department of Health Drug Office 30501
HR Agencija za lijekove i medicinske proizvode HR-H-700996011
JP 医薬品医療機器総合機構 2219403A1027
LT Valstybinė vaistų kontrolės tarnyba 1090497
NL Z-Index G-Standaard 13260251
NL Z-Index G-Standaard, PRK 25941
NZ Medicines and Medical Devices Safety Authority 4284
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W63674001
SG Health Sciences Authority 01509P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.